NxStage Medical Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
65.58 M |
Public Float |
65.13 M |
NxStage Medical Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.23 |
Market Cap |
$1.86 B |
Shares Outstanding |
65.58 M |
Public Float |
64.18 M |
Address |
350 Merrimack Street Lawrence Massachusetts 01843 United States |
Employees | - |
Website | http://www.nxstage.com |
Updated | 09/14/2018 |
NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. |